Business Standard

Sebi approves CAMS KYC registration agency

Related News

The Securities and Exchange Board of India (Sebi) has approved CAMSKRA, a wholly owned subsidiary of (CAMS), to serve as a (KRA). The KRA initiative is aimed to eliminate duplication of KYC efforts which an investor has to undergo while dealing with multiple intermediaries like mutual funds, portfolio management services, private equity funds, brokers and depository participants.

Read more on:   
|
|
|

Sebi approves CAMS KYC registration agency

The Securities and Exchange Board of India (Sebi) has approved CAMSKRA, a wholly owned subsidiary of Computer Age Management Services (CAMS), to serve as a KYC Registration Agency (KRA). The KRA initiative is aimed to eliminate duplication of KYC efforts which an investor has to undergo while dealing with multiple intermediaries like mutual funds, portfolio management services, private equity funds, brokers and depository participants.

The Securities and Exchange Board of India (Sebi) has approved CAMSKRA, a wholly owned subsidiary of (CAMS), to serve as a (KRA). The KRA initiative is aimed to eliminate duplication of KYC efforts which an investor has to undergo while dealing with multiple intermediaries like mutual funds, portfolio management services, private equity funds, brokers and depository participants.

image

Read More

Icra places 14 auto component makers under watch

Rating agency Icra today placed 14 auto component manufacturers on "rating watch with developing implications", following lockout at Maruti Suzuki's ...

Recommended for you

Quick Links

Market News

BSE currency options segment largest in the world

Number of contracts in currency options segment had grown by nearly 30% in March

Nifty ends down 101 points; TCS down 4%, Lupin slumps 7%

The 30-share Sensex ended down 224 points at 28,442 and the 50-share Nifty ended down 101 points at 8,606.

Sensex ends down 242 points; IT shares drag

The 30-share Sensex provisionally ended down 242 points at 28,425 and the 50-share Nifty ended down 104 points at 8,603.

Pharma shares extend fall; CNX Pharma index down 3%

Lupin, Aurobindo, Sun Pharma, Cadila Healthcare, Venus Remedies, SPARC & Shasun Pharma down were 3%-7%.

CRISIL falls from record high on weak March quarter results

The stock down 8% to Rs 2,165 on the NSE after reporting 18% yoy drop in profit at Rs 56 crore in March 2015 quarter.

 

Back to Top